Vitiligo
Author:
Ranawaka Ranthilaka R.
Publisher
Springer Singapore
Reference11 articles.
1. Birlea SA, Ahmad FJ, Uddin RM et al (2013) Association of generalized vitiligo with MHC class II loci in patients from the Indian subcontinent. J Invest Dermatol 133(5):1369–1372. https://doi.org/10.1038/jid.2012.501
2. Damevska K, Peev I, Ranawaka RR, Simeonovski V (2019) Hypopigmentation from chemical and physical agents. In: Hypopigmentation. Taylor & Francis Group, Boca Raton. https://doi.org/10.1201/9781315146454-24
3. Faria AR, Tarlé RG et al (2014) Vitiligo—Part 2—classification, histopathology and treatment. An Bras Dermatol 89(5):784–790. https://doi.org/10.1590/abd1806-4841.20142717
4. Hu W, Xu Y, Ma Y et al (2019) Efficacy of the topical calcineurin inhibitors tacrolimus and pimecrolimus in the treatment of vitiligo in infants under 2 Years of age: a randomized. Open-label pilot study. Clin Drug Investig 39(12):1233–1238. https://doi.org/10.1007/s40261-019-00845-x
5. Kumarasinghe SP (1995) An optimistic approach to treatment of vitiligo. Ceylon Med J 40(3):94–96